MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Acanthoma

(UMLS:C0846967)

Definition:: A neoplasm composed of squamous or epidermal cells.
UMLS ID:: C0846967
MeSH ID:: D049309

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.470.700.040|C04.588.805.040

Synonym(s)

Acanthoma

acanthoma

Associated Drug(s)

	Name	Number of Reports	Data Source
1	Vemurafenib	FAERS: 3	US FAERS
2	Fingolimod Hydrochloride	FAERS: 2	US FAERS
3	Acitretin	FAERS: 1	US FAERS
4	Acebutolol		OFFSIDES
5	Anastrozole		OFFSIDES
6	Caffeine		OFFSIDES
7	Capecitabine		OFFSIDES
8	Cefuroxime		OFFSIDES
9	Chlorhexidine		OFFSIDES
10	Clotrimazole		OFFSIDES
11	Etodolac		OFFSIDES
12	Fluconazole		OFFSIDES
13	Furosemide		OFFSIDES
14	Ketoprofen		OFFSIDES
15	Leflunomide		OFFSIDES
16	Mupirocin		OFFSIDES
17	Orphenadrine		OFFSIDES
18	Pamidronate		OFFSIDES
19	Pergolide		OFFSIDES
20	Pramipexole		OFFSIDES
21	Risedronic Acid		OFFSIDES
22	carbidopa, levodopa drug combination		OFFSIDES
23	cefuroxime axetil		OFFSIDES
24	chlordiazepoxide, clidinium drug combination		OFFSIDES
25	chlorhexidine gluconate		OFFSIDES
26	flupirtine		OFFSIDES
27	rofecoxib		OFFSIDES

Similar ADE(s)

	Name	Semantic Similarity
1	Carcinoma, Papillary	40.7%
2	Squamous cell carcinoma	40.7%
3	Papilloma	35.9%
4	Papillomatosis	35.9%
5	Bowen's Disease	30.6%
6	Neoplasms, Neuroepithelial	28.1%
7	Gliomatosis cerebri	28.1%
8	Basal cell carcinoma	27.6%
9	Cystadenoma	27.6%
10	Mesothelioma	27.6%
11	Carcinoma, Basal Cell	27.6%
12	Adenoma	27.5%
13	Carcinoma	27.5%
14	Epithelioma	27.5%
15	Abdominal Neoplasms	25.8%
16	Head and Neck Neoplasms	25.8%
17	Soft Tissue Neoplasms	25.8%
18	Thoracic Neoplasms	25.8%
19	Carcinoma, Lobular	24.4%
20	Cystadenocarcinoma	24.3%
21	Mucoepidermoid Carcinoma	24.3%
22	leukemia	23.6%
23	Neoplasms, Germ Cell and Embryonal	23.6%
24	Germ Cell Cancer	23.6%
25	Carcinoma, Ehrlich Tumor	23.3%
26	Carcinoma, Lewis Lung	23.3%
27	Hamartoma	22.4%
28	Neoplasms, Hormone-Dependent	22.4%
29	Neoplasms, Multiple Primary	22.4%
30	Paraneoplastic Syndromes	22.4%
31	Precancerous Conditions	22.4%
32	Neoplasms, Second Primary	22.4%
33	Neuroectodermal Tumors	21.5%
34	Sebaceous Gland Neoplasms	20.5%
35	Digestive System Neoplasms	20.4%
36	Endocrine Gland Neoplasms	20.4%
37	Eye Neoplasms	20.4%
38	Nervous System Neoplasms	20.4%
39	Adenoma, Acidophil	20%
40	Ganglioneuroma	20%
41	Glioma	20%
42	Malignant Glioma	20%
43	Medulloblastoma	19.9%
44	Bone neoplasms	19.7%
45	Hematologic Neoplasms	19.7%
46	Splenic Neoplasms	19.3%
47	Meningioma	19.1%
48	Adenofibroma	18.6%
49	Fibroadenoma	18.6%
50	Adenocarcinoma	18.5%
51	Carcinoma in Situ	18.5%
52	Carcinoma, Transitional Cell	18.5%
53	Pseudomyxoma Peritonei	18.5%
54	Adenomatosis, Pulmonary	18.5%
55	Adenomatous Polyps	18.5%
56	Carcinoma, Large Cell	18.5%
57	Carcinoma, Small Cell	18.5%
58	Multiple Endocrine Neoplasia	18%
59	Carcinosarcoma	18%
60	Hemangiosarcoma	18%
61	lymphangiosarcoma	18%
62	Carcinoma 256, Walker	17.8%
63	Paraneoplastic Encephalomyelitis	17.7%
64	Histiocytic Disorders, Malignant	17.6%
65	melanoma	17.5%
66	Carcinoid Tumor	17.4%
67	Mammary Neoplasms, Experimental	17.3%
68	Parathyroid Neoplasms	16.9%
69	Peritoneal Neoplasms	16.9%
70	Thyroid Neoplasm	16.9%
71	Thyroid carcinoma	16.9%
72	Cyst	16.8%
73	Neoplastic Processes	16.8%
74	Neoplastic Syndromes, Hereditary	16.8%
75	Pregnancy Complications, Neoplastic	16.8%
76	Dermoid Cyst	16.7%
77	Carcinoma, Pancreatic Ductal	16.7%
78	Neoplasms, Experimental	16.5%
79	Retroperitoneal Neoplasms	16.5%
80	Trophoblastic Neoplasms	16.1%
81	Astrocytoma	16%
82	Ependymoma	16%
83	oligodendroglioma	16%
84	Ganglioglioma	16%
85	gliosarcoma	16%
86	Anaplastic astrocytoma	16%
87	Anaplastic Oligodendroglioma	16%
88	Leukemia, Experimental	16%
89	Thymoma	15.8%
90	Choriocarcinoma	15.7%
91	Retinoblastoma	15.3%
92	Hepatocellular Adenoma	15.3%
93	Melanoma, Experimental	14.9%
94	Malignant Carcinoid Syndrome	14.7%
95	Chondrosarcoma	14.6%
96	Craniopharyngioma	14.6%
97	leiomyosarcoma	14.6%
98	liposarcoma	14.6%
99	Pancreatic Neoplasm	14.6%
100	synovial sarcoma	14.6%
101	Neuroectodermal Tumor, Melanotic	14.6%
102	Angiomyolipoma	14.6%
103	Clear Cell Sarcoma of Soft Tissue	14.6%
104	Alveolar Soft Part Sarcoma	14.6%
105	Neuroendocrine Tumors	14.6%
106	Sarcoma, Myeloid	14.6%
107	Tracheal Neoplasms	14.6%
108	Leukemia, Plasma Cell	14.4%
109	Ameloblastoma	14.3%
110	Angiokeratoma	14.3%
111	Chordoma	14.3%
112	Hemangioma	14.3%
113	hemangiopericytoma	14.3%
114	Lymphangioma	14.3%
115	Mesenchymoma	14.3%
116	Nevus	14.3%
117	Teratoma	14.3%
118	Hepatoblastoma	14.3%
119	Mixed Tumor, Mullerian	14.3%
120	Germinoma	14.3%
121	Teratocarcinoma	14.3%
122	Angiofibroma	14.3%
123	Sarcoma	14.3%
124	Composite Lymphoma	14.2%
125	Lymphoma	14.1%
126	Glioblastoma	14.1%
127	Neuroblastoma	14.1%
128	Glioblastoma Multiforme	14.1%
129	Adenoid Cystic Carcinoma	14.1%
130	Adenocarcinoma, Clear Cell	14.1%
131	Cholangiocarcinoma	14.1%
132	Cervical Intraepithelial Neoplasia	14.1%
133	Neurilemmoma	13.5%
134	Hutchinson's Melanotic Freckle	13.5%
135	Melanoma, Amelanotic	13.5%
136	Leukemia, Radiation-Induced	13.5%
137	Sarcoma, Experimental	13.2%
138	Neoplasms, Radiation-Induced	13.2%
139	Leukemia L1210	13.1%
140	Leukemia P388	13.1%
141	Ganglioneuroblastoma	13.1%
142	Prolactinoma	13%
143	Growth Hormone-Secreting Pituitary Adenoma	13%
144	Fibrosarcoma	13%
145	Osteosarcoma	13%
146	Mouth Neoplasms	12.6%
147	Central Nervous System Neoplasms	12.6%
148	Vascular Neoplasms	12.6%
149	Thymus Neoplasms	12.6%
150	Vipoma	12.5%
151	insulinoma	12.5%
152	Genital Neoplasms, Female	12.4%
153	Erythroplasia	12.4%
154	Follicular cyst	12.4%
155	Mucocele	12.4%
156	Pilonidal Cyst	12.4%
157	Thyroglossal Cyst	12.4%
158	Synovial Cyst	12.4%
159	Aberrant Crypt Foci	12.4%
160	Breast Neoplasms, Male	12.3%
161	Triple Negative Breast Neoplasms	12.3%
162	Esophageal Neoplasms	12.3%
163	Basal Cell Nevus Syndrome	12.2%
164	Malignant Fibrous Histiocytoma	12.1%
165	Thyroid Nodule	12%
166	Klatskin Tumor	11.9%
167	Multiple Endocrine Neoplasia Type 1	11.7%
168	Gastrinoma	11.7%
169	Glucagonoma	11.7%
170	Sarcoma 180	11.4%
171	Carcinoid Heart Disease	11.4%
172	Carcinoma, Ovarian Epithelial	11.3%
173	Paraganglioma	11.3%
174	Rhabdomyosarcoma	11.3%
175	Giant Cell Tumor of Bone	11.3%
176	Acoustic Neuroma	11.3%
177	Optic Nerve Glioma	11.2%
178	Testicular Neoplasms	10.8%
179	Nephroblastoma	10.8%
180	Plasmacytoma	10.7%
181	Endometrial Stromal Sarcoma	10.7%
182	Malignant histiocytosis	10.7%
183	Histiocytic sarcoma	10.7%
184	Dermatofibrosarcoma	10.5%
185	Dermatofibrosarcoma Protuberans	10.5%
186	Liver Neoplasms, Experimental	10.4%
187	Adrenal Gland Neoplasms	10.2%
188	Gastrointestinal Neoplasms	10.2%
189	Genital Neoplasms, Male	10.2%
190	Liver neoplasms	10.2%
191	Uveal Neoplasms	10.2%
192	Tuberous Sclerosis	10.1%
193	Adrenocortical carcinoma	10.1%
194	Urologic Neoplasms	10.1%
195	Spinal Neoplasms	9.9%
196	Bone Marrow Neoplasms	9.9%
197	Leukoplakia, Oral	9.9%
198	Paraneoplastic Cerebellar Degeneration	9.8%
199	Phyllodes Tumor	9.8%
200	Dysgerminoma	9.8%
201	Hemangioendothelioma	9.8%
202	Lipoma	9.8%
203	Lymphomatoid Granulomatosis	9.8%
204	Myoma	9.8%
205	Myxoma	9.8%
206	Neuroma	9.8%
207	Seminoma	9.8%
208	Angiolipoma	9.8%
209	Myelolipoma	9.8%
210	Neoplasms, Bone Tissue	9.8%
211	Neoplasms, Fibrous Tissue	9.8%
212	Smooth Muscle Tumor	9.8%
213	Desmoplastic Small Round Cell Tumor	9.8%
214	Chondroma	9.8%
215	Enchondroma	9.8%
216	Lymphangioleiomyomatosis	9.7%
217	Pheochromocytoma	9.6%
218	Alveolar rhabdomyosarcoma	9.6%
219	Adenomatous Polyposis Coli	9.4%
220	Leukoplakia	9.4%
221	Lymphocele	9.4%
222	Pancreatic Cyst	9.4%
223	Barrett Esophagus	9.2%
224	Breast Cyst	9.2%
225	Actinic keratosis	9.2%
226	Mediastinal Cyst	9.2%
227	Neoplasm Invasiveness	9.2%
228	Neoplasm Metastasis	9.2%
229	Neoplasm Recurrence, Local	9.2%
230	Parovarian Cyst	9.2%
231	Pericardial Cyst	9.2%
232	Thymic Cyst	9.2%
233	Carcinogenesis	9.2%
234	Myxoid cyst	9.2%
235	Metastasis	9.2%
236	Neurofibrosarcoma	9.1%
237	Meningeal Neoplasms	9%
238	Nasopharyngeal carcinoma	9%
239	Mesoblastic Nephroma	8.9%
240	Renal Cell Carcinoma	8.8%
241	Papillary Renal Cell Carcinoma	8.8%
242	Leydig Cell Tumor	8.5%
243	Hodgkin Disease	8.5%
244	Lymphoma, Non-Hodgkin	8.5%
245	Limbic Encephalitis	8.4%
246	Carcinoma, Endometrioid	8.4%
247	Nose Neoplasms	8.3%
248	Palatal Neoplasms	8.2%
249	granulosa cell tumor	8.1%
250	Hydatidiform Mole	7.7%
251	fibroma	7.6%
252	Fibromatosis	7.6%
253	Osteoblastoma	7.6%
254	Osteoma	7.6%
255	Rhabdomyoma	7.6%
256	Chondromatosis	7.6%
257	Hemangioblastoma	7.6%
258	Lymphoma, Extranodal NK-T-Cell	7.6%
259	Lambert-Eaton Myasthenic Syndrome	7.5%
260	Ear Neoplasms	7.4%
261	Eyelid Neoplasms	7.4%
262	Lung Neoplasms	7.4%
263	Pleural Neoplasms	7.4%
264	Pituitary Adenoma	7.4%
265	Pituitary Neoplasms	7.4%
266	Leukemia, Myelomonocytic, Chronic	7.3%
267	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	7.3%
268	Corpus Luteum Cyst	7.3%
269	Ovarian Cysts	7.3%
270	Meningeal Carcinomatosis	7.3%
271	Brain Neoplasms	7.2%
272	Salivary Gland Neoplasms	7.2%
273	Spinal Cord Neoplasms	7.2%
274	Tongue Neoplasms	7.2%
275	Uterine Neoplasms	7.1%
276	Vaginal Neoplasms	7.1%
277	Vulvar Neoplasms	7.1%
278	Uterine Cancer	7.1%
279	Primary amyloidosis	7.1%
280	Fallopian Tube Neoplasms	7.1%
281	ovarian neoplasm	7.1%
282	Neoplasms, Glandular and Epithelial	6.7%
283	Opsoclonus-Myoclonus Syndrome	6.6%
284	Fibromatosis, Aggressive	6.5%
285	Fibromatosis, Abdominal	6.5%
286	Pharyngeal Neoplasms	6.2%
287	Choledochal Cyst	6.2%
288	Central Nervous System Cysts	6.1%
289	Peutz-Jeghers Syndrome	6.1%
290	Bile Duct Neoplasms	6%
291	gallbladder neoplasm	6%
292	Intestinal Neoplasms	6%
293	Penile Neoplasms	6%
294	Prostatic Neoplasms	6%
295	Stomach Neoplasms	6%
296	Mastocytosis	6%
297	Sturge-Weber Syndrome	6%
298	Bronchial Neoplasms	6%
299	Polycythemia Vera	5.9%
300	Gastrointestinal Stromal Tumors	5.9%
301	Myelitis, Transverse	5.9%
302	Multiple Pulmonary Nodules	5.9%
303	Hemangioma, Cavernous	5.9%
304	Leukemia, T-Cell	5.8%
305	Leukemia, B-Cell	5.8%
306	neurofibroma	5.8%
307	Supratentorial Neoplasms	5.8%
308	Lymphoma, Follicular	5.8%
309	T-Cell Lymphoma	5.8%
310	Mantle cell lymphoma	5.8%
311	Endometrial Neoplasms	5.8%
312	Pancreatic Pseudocyst	5.8%
313	Lymphatic Metastasis	5.7%
314	Neoplasms, Unknown Primary	5.7%
315	Leukemic Infiltration	5.7%
316	Neoplasm Micrometastasis	5.7%
317	Mastocytoma	5.7%
318	Mastocytosis, Systemic	5.7%
319	Leukemia, Myeloid, Chronic-Phase	5.6%
320	Denys-Drash Syndrome	5.5%
321	Laryngeal neoplasm	5.4%
322	Waldenstrom Macroglobulinemia	5.3%
323	Multiple Myeloma	5.3%
324	Bladder Neoplasm	5.1%
325	Kidney Neoplasm	5.1%
326	Ureteral Neoplasms	5.1%
327	Urethral Neoplasms	5.1%
328	Brain Stem Neoplasms	5.1%
329	Hypopharyngeal Neoplasms	4.9%
330	Pleural Effusion, Malignant	4.9%
331	Hypopharyngeal Cancer	4.9%
332	Acanthoma	4.9%
333	Parotid Neoplasms	4.9%
334	Prostatic Neoplasms, Castration-Resistant	4.9%
335	Nelson Syndrome	4.8%
336	Choroid Plexus Papilloma	4.8%
337	Polycystic Ovary Syndrome	4.6%
338	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	4.5%
339	Leukemia, Large Granular Lymphocytic	4.5%
340	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	4.5%
341	Lymphoma, T-Cell, Cutaneous	4.5%
342	Lymphoma, AIDS-Related	4.5%
343	Enteropathy-Associated T-Cell Lymphoma	4.5%
344	Primary Effusion Lymphoma	4.5%
345	Tonsillar Neoplasms	4.3%
346	Cerebellar Neoplasms	4.3%
347	Skin Neoplasms	4.3%
348	Cecal Neoplasms	4.2%
349	Duodenal Neoplasms	4.2%
350	Dupuytren Contracture	4%
351	Urticaria Pigmentosa	3.9%
352	Mycosis Fungoides	3.8%
353	Lymphomatoid Papulosis	3.8%
354	Plasmablastic lymphoma	3.8%
355	Nasopharyngeal Neoplasms	3.7%
356	Xeroderma Pigmentosum	3.7%
357	Appendiceal Neoplasms	3.7%
358	Colonic Neoplasms	3.7%
359	Rectal Neoplasms	3.7%
360	Colorectal Neoplasms	3.6%
361	Paranasal Sinus Neoplasms	3.3%
362	Cell Transformation, Viral	3.3%
363	Burkitt Lymphoma	3.2%
364	Anus Neoplasms	3%
365	Sigmoid Neoplasms	3%
366	Maxillary Sinus Neoplasms	2.9%
367	Sezary Syndrome	2.8%
368	Zollinger-Ellison syndrome	2.6%
369	Radicular Cyst	1.6%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262